Administration of mesenchymal stem cells (MSCs) to diseased hearts improves cardiac
function and reduces scar. These effects occur via stimulation of endogenous repair …

The amniotic fluid has been identified as an untapped source of cells with broad potential,
which possess immunomodulatory properties and do not have the ethical and legal …

Mesenchymal stem/stromal cells (MSCs) are currently one of the most extensively
researched fields due to their promising opportunity for use in regenerative medicine. There …

BACKGROUND: There are a lot of different types of sunscreen products (oils, sticks, gels,
creams, lotions) which can be found on the world's market. Sunscreen product that contains …

The placenta is a temporary organ that is discarded after birth and is one of the most
promising sources of various cells and tissues for use in regenerative medicine and tissue …

Background Currently, there is no effective treatment for premature ovarian failure (POF),
and stem cell therapy is considered the most promising treatment. Human umbilical cord …

Background: Amniotic Fluid Derived Mesenchymal Stem Cells (AF-MSCs) are adult,
fibroblast-like, self-renewable, multipotent stem cells. During the last decade, the therapeutic …

Mesenchymal stem cells (MSCs) have extensive potentials, which make them attractive
candidates for the developmental biology, drug discovery and regenerative medicine …

Human amniotic fluid cells are immune‐privileged with low immunogenicity and anti‐
inflammatory properties. They are able to self‐renew, are highly proliferative, and have a …

Human endometrium derived mesenchymal stem cells (hEndSCs) offer a great promise for
regenerative medicine and reproductive system disorders treatment methods based on cell …